{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:21:12Z","timestamp":1792185672579,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40265-015-0407-9","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T04:20:21Z","timestamp":1432700421000},"page":"1019-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extended-Cycle Levonorgestrel\/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique\u00ae): A Review of Its Use as an Oral Contraceptive"],"prefix":"10.1007","volume":"75","author":[{"given":"Celeste B.","family":"Burness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"issue":"1","key":"407_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2010.11.004","volume":"84","author":"R Burkman","year":"2011","unstructured":"Burkman R, Bell C, Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception. 2011;84(1):19\u201334.","journal-title":"Contraception."},{"key":"407_CR2","unstructured":"Faculty of Sexual and Reproductive Healthcare. Faculty of Sexual and Reproductive Healthcare clinical guidance: combined hormonal contraception. 2012. http:\/\/www.fsrh.org\/pdfs\/CEUGuidanceCombinedHormonalContraception.pdf . Accessed 27 Mar 2015."},{"key":"407_CR3","author":"A Edelman","year":"2014","unstructured":"Edelman A, Micks E, Gallo MF, et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014; doi: 10.1002\/14651858.CD004695.pub3 .","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"407_CR4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.contraception.2009.06.010","volume":"80","author":"E Hardy","year":"2009","unstructured":"Hardy E, Hebling EM, de Sousa MH, et al. Association between characteristics of current menses and preference for induced amenorrhea. Contraception. 2009;80(3):266\u20139.","journal-title":"Contraception."},{"issue":"2","key":"407_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","volume":"89","author":"PJ Sulak","year":"1997","unstructured":"Sulak PJ, Cressman BE, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol. 1997;89(2):179\u201383.","journal-title":"Obstet Gynecol."},{"key":"407_CR6","unstructured":"Duramed Pharmaceutical Inc. SEASONALE (levonorgestrel\/ethinyl estradiol tablets) 0.15\u00a0mg\/0.03\u00a0mg. 2003. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-544_SEASONALE_Prntlbl.pdf . Accessed 27 Mar 2015."},{"issue":"2","key":"407_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","volume":"68","author":"FD Anderson","year":"2003","unstructured":"Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68(2):89\u201396.","journal-title":"Contraception."},{"key":"407_CR8","unstructured":"Teva Woman\u2019s Health. SEASONIQUE (levonorgestrel\/ethinyl estradiol and ethinyl estradiol): US prescribing infomation. 2013. http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=47373 . Accessed 27 Mar 2015."},{"key":"407_CR9","unstructured":"Teva Pharmaceutical Industries Ltd. Seasonique\u00ae: summary of product characteristics: Teva Pharmaceutical Industries Ltd; 2015."},{"key":"407_CR10","unstructured":"Teva Women\u2019s Health. LOSEASONIQUE-levonorgestrel\/ethinylestradiol and ethinylestradiol: US prescribing infomation. 2012. http:\/\/dailymed.nlm.nih.gov\/ . Accessed 27 Mar 2015."},{"issue":"1","key":"407_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2007.09.010","volume":"77","author":"KZ Reape","year":"2008","unstructured":"Reape KZ, DiLiberti CE, Hendy CH, et al. Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive. Contraception. 2008;77(1):34\u20139.","journal-title":"Contraception."},{"issue":"3","key":"407_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","volume":"77","author":"MA Vandever","year":"2008","unstructured":"Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77(3):162\u201370.","journal-title":"Contraception."},{"key":"407_CR13","author":"R Kroll","year":"2014","unstructured":"Kroll R, Seidman L, Ricciotti N, et al. A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. Eur J Contracept Reprod Health Care. 2014; doi: 10.3109\/13625187.2014.979282 .","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"2","key":"407_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2007.11.006","volume":"77","author":"FD Anderson","year":"2008","unstructured":"Anderson FD, Feldman R, Reape KZ. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo. Contraception. 2008;77(2):91\u20136.","journal-title":"Contraception."},{"issue":"6","key":"407_CR15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-11-1047","volume":"166","author":"D Cibula","year":"2012","unstructured":"Cibula D, Skrenkova J, Hill M, et al. Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. Eur J Endocrinol. 2012;166(6):1003\u201311.","journal-title":"Eur J Endocrinol."},{"key":"407_CR16","unstructured":"Cromer B, Gersten J, Hsieh J, et al. Comparative effects of a 91-day or a 28-day combined oral contraceptive on bone mineral density in adolescents [abstract plus poster]. In: The 23rd European Congress of Obstetrics and Gynaecology (EBCOG). 2014."},{"key":"407_CR17","author":"M Bastos de","year":"2014","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014; doi: 10.1002\/14651858.CD010813.pub2 .","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"407_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","volume":"126","author":"MK Barsoum","year":"2010","unstructured":"Barsoum MK, Heit JA, Ashrani AA, et al. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res. 2010;126(5):373\u20138.","journal-title":"Thromb Res."},{"issue":"4","key":"407_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/13625187.2014.918596","volume":"19","author":"RE Nappi","year":"2014","unstructured":"Nappi RE, Paoletti AM, Volpe A, et al. Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women. Eur J Contracept Reprod Health Care. 2014;19(4):285\u201394.","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"1","key":"407_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2010.06.015","volume":"83","author":"CE DiLiberti","year":"2011","unstructured":"DiLiberti CE, O\u2019Leary CM, Hendy CH, et al. Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen. Contraception. 2011;83(1):55\u201361.","journal-title":"Contraception."},{"issue":"3","key":"407_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","volume":"73","author":"FD Anderson","year":"2006","unstructured":"Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception. 2006;73(3):229\u201334.","journal-title":"Contraception."},{"key":"407_CR22","unstructured":"European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) assessment report for Seasonique\u00ae and associated names. 2014. http:\/\/www.ema.europa.eu\/ . Accessed 27 Mar 2015."},{"issue":"5","key":"407_CR23","first-page":"E9","volume":"59","author":"MG Davis","year":"2010","unstructured":"Davis MG, Reape KZ, Hait H. A look at the long-term safety of an extended-regimen OC. J Fam Pract. 2010;59(5):E9\u201313.","journal-title":"J Fam Pract."},{"issue":"1","key":"407_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2013.09.007","volume":"89","author":"B Howard","year":"2014","unstructured":"Howard B, Trussell J, Grubb E, et al. Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report. Contraception. 2014;89(1):25\u20137.","journal-title":"Contraception."},{"issue":"7","key":"407_CR25","doi-asserted-by":"crossref","first-page":"A543","DOI":"10.1016\/j.jval.2012.08.1915","volume":"15","author":"C Brewster","year":"2012","unstructured":"Brewster C, Lage MJ, Grubb E. Comparison of unintended pregnancy rates among women who initiated oral contraceptive therapy with a 84\/7 estradiol or a 84\/7 placebo [abstract no. PIH43]. Value Health. 2012;15(7):A543\u20134.","journal-title":"Value Health."},{"issue":"5","key":"407_CR26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2008.11.011","volume":"79","author":"AM Kaunitz","year":"2009","unstructured":"Kaunitz AM, Portman DJ, Hait H, et al. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive. Contraception. 2009;79(5):350\u20135.","journal-title":"Contraception."},{"issue":"5","key":"407_CR27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","volume":"88","author":"J Trussell","year":"2013","unstructured":"Trussell J, Portman D. The creeping Pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills? Contraception. 2013;88(5):604\u201310.","journal-title":"Contraception."},{"key":"407_CR28","doi-asserted-by":"crossref","first-page":"f3251","DOI":"10.1136\/bmj.f3251","volume":"346","author":"MA Lumsden","year":"2013","unstructured":"Lumsden MA, Gebbie A, Holland C. Managing unscheduled bleeding in non-pregnant premenopausal women. BMJ. 2013;346:f3251.","journal-title":"BMJ."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-015-0407-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-015-0407-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-015-0407-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:42Z","timestamp":1559490102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-015-0407-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s40265-015-0407-9","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]}}}